Commitment to Cures 2023: A huge success!

The Commitment to Cures gala took place on April 26, 2023 in Boston. The evening was packed with special entertainment and inspiring stories from advocates and researchers who are working towards the cures of tomorrow.

Thanks to our community’s incredible generosity, we raised over $565,000—all of it going to support critical brain disease research.

We had a record number of event sponsors with 36 individuals, businesses, and academic institutions partnering with us. You can check them out at the bottom of this page.

To all who made a donation: Thank you. Your support helps to fund life-changing research projects.

Donate

Ticket sales have ended. You can still donate to support Commitment to Cures!

April 26th, 2023

Cocktail Reception: 6:00 p.m. – 7:00 p.m.
Dinner & Program: 7:00 p.m.

Location: Omni Boston Hotel at the Seaport, Boston, MA

HOST

Jim Cramer

Jim Cramer, host of CNBC’s Mad Money, lived for years with undiagnosed migraine before finally receiving a diagnosis and finding a treatment plan that helped him manage his attacks. He is now committed to raising migraine awareness and supporting research that will lead to new treatments and cures. Jim advocates for the nearly 40 million Americans living with migraine, and we are honored to have him as our host.

Public Leadership in Neurology Award

Arianna Huffington

Founder of HuffPost, Arianna Huffington will be honored for raising public awareness of the importance of sleep and brain health through her writing, speaking and by founding Thrive Global, a company that uses science to improve mental and physical well-being.

Ambassador Award

Peter Frampton

Celebrated singer and guitarist, Peter Frampton, will be honored for elevating public awareness of Inclusion-Body Myositis and for establishing the Peter Frampton Myositis Research Fund at Johns Hopkins University to raise money for research.

Scientific Breakthrough Award

Josep Dalmau, MD, PhD, FAAN & Vanda Lennon, MD, PhD

Their collective body of work has defined and transformed the field of autoimmune and paraneoplastic neurology and has had a major impact on the diagnosis and care of patients with autoimmune neurological diseases around the world.